| Code | 0705C | ||||||||||
| MA number | 69/0378/16-S | ||||||||||
| Product Form: | pas ord 36x5 mg/1 mg (blis.PVC/PCTFE/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Laboratoria QUALIPHAR N.V./S.A., Belgium | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PCTFE/Al | ||||||||||
| Route of admin.: | Oromucosal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 04.08.2016 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| SPC: |
SPC_Faryngal 5 mg_1 mg tvrdé pastilky_05/2025.pdf
|
| PIL: |
PIL_Faryngal 5 mg_1 mg tvrdé pastilky_05/2025.pdf
|
| Safety feature | No |
| Data update: | 06.06.2025 |
